YY (ADR) (YY) EPS Estimated At $1.34; Shorts at PETLIFE PHARMACEUTICALS (PTLF) Lowered By 89.02%

August 7, 2017 - By Maria Brooks

PETLIFE PHARMACEUTICALS INCORPORATED (OTCMKTS:PTLF) had a decrease of 89.02% in short interest. PTLF’s SI was 4,600 shares in August as released by FINRA. Its down 89.02% from 41,900 shares previously. The stock increased 9.00% or $0.013 on August 4, reaching $0.163. About shares traded. Petlife Pharmaceuticals Inc (OTCMKTS:PTLF) has 0.00% since August 7, 2016 and is . It has underperformed by 16.70% the S&P500.

Analysts expect YY Inc (ADR) (NASDAQ:YY) to report $1.34 EPS on August, 16.They anticipate $0.44 EPS change or 48.89% from last quarter’s $0.9 EPS. YY’s profit would be $74.58M giving it 13.71 P/E if the $1.34 EPS is correct. After having $1.34 EPS previously, YY Inc (ADR)’s analysts see 0.00% EPS growth. The stock decreased 0.80% or $0.59 on August 4, reaching $73.49. About shares traded. YY Inc (ADR) (NASDAQ:YY) has risen 20.20% since August 7, 2016 and is uptrending. It has outperformed by 3.50% the S&P500.

PetLife Pharmaceuticals, Inc. is a veterinary pharmaceutical company. The company has market cap of $11.36 million. The Firm specializes in the research, development, sales and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis. It currently has negative earnings. The Firm has developed and is launching veterinary cancer medications and nutraceuticals, based on the Escozine formula.

YY Inc. is a social platform that engages users in real-time online group activities through voice, video and text on personal computers and mobile devices. The company has market cap of $4.09 billion. The Company’s divisions include YY IVAS and others, Huya broadcasting, and 100 Education. It has a 15.75 P/E ratio. YY enables users to create and organize groups of varying sizes to discover and participate in a range of online activities, including music shows, online games, dating shows, live game broadcasting and e-learning.

Among 5 analysts covering YY Inc (NASDAQ:YY), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. YY Inc had 10 analyst reports since August 17, 2015 according to SRatingsIntel. Jefferies maintained the shares of YY in report on Monday, July 17 with “Hold” rating. The stock of YY Inc (ADR) (NASDAQ:YY) earned “Buy” rating by Bank of America on Monday, November 28. JP Morgan initiated YY Inc (ADR) (NASDAQ:YY) rating on Wednesday, August 31. JP Morgan has “Overweight” rating and $62 target. On Thursday, August 20 the stock rating was downgraded by Zacks to “Hold”. The firm earned “Overweight” rating on Friday, August 14 by Piper Jaffray. The rating was initiated by Jefferies on Wednesday, February 8 with “Hold”. Jefferies maintained it with “Hold” rating and $5600 target in Friday, June 16 report. The firm has “Sector Weight” rating by Pacific Crest given on Monday, August 17. The stock of YY Inc (ADR) (NASDAQ:YY) has “Buy” rating given on Tuesday, July 4 by Bank of America. The company was initiated on Monday, October 31 by HSBC.